午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

懷化元研達(dá)生物技術(shù)有限責(zé)任公司 公司信息

公司名稱: 懷化元研達(dá)生物技術(shù)有限責(zé)任公司
電話: -
電子郵件:18711085600@163.com
國籍:中國
網(wǎng)址:
產(chǎn)品總數(shù):4590
37 38 39 40 41 42 43 44 45 46

公司提供產(chǎn)品列表

Dabigatran Impurity P 達(dá)比加群雜質(zhì) P 212322-56-0
Olmesartan Medoxomil Impurity6 奧美沙坦酯雜質(zhì)6 144690-06-2
Dabigatran Impurity L 達(dá)比加群雜質(zhì) L 1580491-16-2
Linezolid Impurity16 利奈唑胺雜質(zhì)16 384344-17-6
Levocetirizine Impurity 3 左西替利嗪雜質(zhì)3 109806-71-5
Olmesartan Medoxomil Impurity12 奧美沙坦酯雜質(zhì)12 172875-59-1
Gefitinib Impurity 9 吉非替尼雜質(zhì) 9 194423-17-1
Dabigatran etexilate impurity15 達(dá)比加群酯雜質(zhì)15 211914-51-1
Olmesartan Medoxomil Impurity3 奧美沙坦酯雜質(zhì)3 154709-18-9
Olmesartan Medoxomil Impurity4 奧美沙坦酯雜質(zhì)4 144690-53-9
LCZ696 impurities4 LCZ696雜質(zhì)4 149709-60-4
Troxagliptin impuritiesT 曲格列汀雜質(zhì)T 850649-61-5
Gefitinib Impurity 4 吉非替尼雜質(zhì) 4 861453-16-9
Clopidogrel Impurities7 氯吡格雷雜質(zhì)7 2173294-69-2
Erlotinib Impurity5 厄洛替尼雜質(zhì)5 54060-30-9
Erlotinib O-Desmethyl Metabolite Isomer (M13) 厄洛替尼 O-去甲基代謝物異構(gòu)體 (M13) 183320-29-8
Clopidogrel Impurities6 氯吡格雷雜質(zhì)6 28783-41-7
Afatinib Impurity13 阿法替尼雜質(zhì)13 1194097-41-0
Dabigatran Impurity K 達(dá)比加群雜質(zhì) K 211915-00-3
Afatinib ImpurityC 阿法替尼雜質(zhì)C 945553-91-3
Afatinib Impurity4 阿法替尼雜質(zhì)4 162012-69-3
Sorafenib impurities12 索拉非尼雜質(zhì)12 1285533-84-7
Gefitinib Impurity 7 吉非替尼雜質(zhì) 7 184475-71-6
alogliptin impurities3 阿格列汀雜質(zhì)3 1268836-55-0
Dabigatran Impurity 17 達(dá)比加群雜質(zhì) 17 1422495-93-9
Dabigatran etexilate impurity8 達(dá)比加群酯雜質(zhì)8 255706-13-9
Clopidogrel EP Impurity C Sulfate 氯吡格雷 EP 雜質(zhì) C 硫酸鹽 120202-71-3
Clopidogrel Impurities9 氯吡格雷雜質(zhì)9 135046-48-9
Linezolid Impurity1 利奈唑胺雜質(zhì)1 1997296-64-6
Gefitinib Impurity 10 吉非替尼雜質(zhì) 10 1006378-06-8
Linezolid Impurity 23 利奈唑胺雜質(zhì)23 216869-17-9
Olmesartan Medoxomil Impurity16 奧美沙坦酯雜質(zhì)16 144690-92-6
Erlotinib O-Desmethyl Metabolite Isomer (M14) 厄洛替尼 O-去甲基代謝物異構(gòu)體 (M14) 183321-86-0
Olmesartan Medoxomil Impurity18 奧美沙坦酯雜質(zhì)18 157356-74-6
Dabigatran etexilate impurityE 達(dá)比加群酯雜質(zhì)E 1610758-22-9
Dabigatran Impurity 24 達(dá)比加群雜質(zhì) 24 1456889-80-7
Afatinib Impurity8 阿法替尼雜質(zhì)8 314771-76-1
alogliptin impurities11 阿格列汀雜質(zhì)11 1618644-29-3
LCZ696 impurities518-12 LCZ696雜質(zhì)518-12 1639970-62-9
Sorafenib impurities9 索拉非尼雜質(zhì)9 573673-43-5
Sorafenib impurities1 索拉非尼雜質(zhì)1 370-50-3
Olmesartan Medoxomil Impurity2 奧美沙坦酯雜質(zhì)2 761404-85-7
Gefitinib Impurity 8 吉非替尼雜質(zhì) 8 675126-28-0
Azilsartan medoxomil impurity4 阿齊沙坦酯雜質(zhì)4 1442400-68-1
Erlotinib Impurity3 厄洛替尼雜質(zhì)3 183319-69-9
Cetirizine EP Impurity A 西替利嗪 EP 雜質(zhì) A 303-26-4
Troxagliptin impuritiesS 曲格列汀雜質(zhì)S 1917324-15-2
Dabigatran etexilate impurity13 達(dá)比加群酯雜質(zhì)13 1408238-40-3
Olmesartan Medoxomil Impurity15 奧美沙坦酯雜質(zhì)15 1227626-51-8
Afatinib Impurity12 阿法替尼雜質(zhì)12 162012-70-6
Dabigatran etexilate impurity12 達(dá)比加群酯雜質(zhì)12 1422435-41-3
Olmesartan Medoxomil Impurity17 奧美沙坦酯雜質(zhì)17 2101308-74-9
alogliptin impurities5 阿格列汀雜質(zhì)5 1820685-30-0
Olmesartan Medoxomil EP Impurity D 奧美沙坦酯 EP 雜質(zhì) D 1020157-01-0
Sorafenib impurities8 索拉非尼雜質(zhì)8 284461-74-1
Azilsartan medoxomil Impurity D 阿齊沙坦酯雜質(zhì)D 1821386-21-3
Linezolid Impurity 22 利奈唑胺雜質(zhì)22 1610690-08-8
Clopidogrel EP Impurity B 氯吡格雷EP雜質(zhì)B 1396841-05-6
Linezolid Impurity12 利奈唑胺雜質(zhì)12 2307625-63-2
N,O-Desethylene Linezolid N,O-去乙烯利奈唑胺 1219708-30-1
Sorafenib impurities11 索拉非尼雜質(zhì)11 583840-03-3
Levocetirizine Impurity 2 左西替利嗪雜質(zhì)2 1150310-68-1
Troxagliptin impurities2 曲格列汀雜質(zhì)2 1812193-01-3
Linezolid Impurity5 利奈唑胺雜質(zhì)5 556801-09-3
Troxagliptin impuritiesI 曲格列汀雜質(zhì)I 1917324-13-0
Dechlorocetirizine dihydrochloride 脫氯西替利嗪二鹽酸鹽 83881-54-3
Afatinib ImpurityD 阿法替尼雜質(zhì)D 1680184-59-1
Troxagliptin impurities5 曲格列汀雜質(zhì)5 2087874-92-6
Cetirizine USP Impurity B 西替利嗪USP雜質(zhì)B 108983-83-1
Linezolid Impurity17 利奈唑胺雜質(zhì)17 333753-71-2
Linezolid Impurity 19 利奈唑胺雜質(zhì)19 1532560-87-4
alogliptin impurities10 阿格列汀雜質(zhì)10 865758-95-8
Linezolid Impurity 18 利奈唑胺雜質(zhì)18 174649-09-3
Sorafenib impurities2 索拉非尼雜質(zhì)2 1431697-81-2
Clopidogrel EP Impurity F HCl 氯吡格雷 EP 雜質(zhì) F HCl 141109-19-5
Oxcarbazepine EP Impurity K 奧卡西平 EP 雜質(zhì) K 1346601-76-0
Linezolid Impurity10 利奈唑胺雜質(zhì)10 168828-81-7
Dabigatran Etexilate N-Oxide 達(dá)比加群酯 N-氧化物 1381757-44-3
Azilsartan medoxomil Impurity M 阿齊沙坦酯雜質(zhì)M 632322-61-3
alogliptin impurities14 阿格列汀雜質(zhì)14 309956-78-3
Sorafenib impurities12 索拉非尼雜質(zhì)12 2204442-52-2
Clopidogrel EP Impurity E(R) 氯吡格雷 EP 雜質(zhì) E(R) 444728-15-8
Olmesartan Medoxomil Impurity1 奧美沙坦酯雜質(zhì)1 144689-23-6
Troxagliptin impurities3 曲格列汀雜質(zhì)3 1821400-07-0
Dabigatran etexilate impurity5 達(dá)比加群酯雜質(zhì)5 872728-85-3
Dabigatran Impurity 20 達(dá)比加群雜質(zhì) 20 1422435-40-2
alogliptin impurities12 阿格列汀雜質(zhì)12 2276323-24-9
Azilsartan medoxomil impurity2 阿齊沙坦酯雜質(zhì)2 1442400-65-8
Dabigatran etexilate impurity7 達(dá)比加群酯雜質(zhì)7 1642853-67-5
LCZ696 impuritiesF LCZ696雜質(zhì)F 1012341-54-6
Oxcarbazepine EP Impurity G 奧卡西平 EP 雜質(zhì) G 1219170-51-0
Levocetirizine Impurity 4 左西替利嗪雜質(zhì)4 58023-19-1
Azilsartan medoxomil Impurity O 阿齊沙坦雜質(zhì)O 1675221-59-6
Olmesartan Medoxomil Impurity9 奧美沙坦酯雜質(zhì)9 51802-42-7
Linezolid Impurity9 利奈唑胺雜質(zhì)9 348626-43-7
Sorafenib impurities13 索拉非尼雜質(zhì)13 220000-87-3
Cetirizine EP Impurity E 西替利嗪 EP 雜質(zhì) E 682323-77-9
Sorafenib impurities3 索拉非尼雜質(zhì)3 2004659-83-8
Azilsartan medoxomil Impurity A 阿齊沙坦雜質(zhì)A 147404-76-0
Gefitinib Impurity 1 吉非替尼雜質(zhì) 1 230955-75-6
37 38 39 40 41 42 43 44 45 46
Copyright 2007? ChemicalBook. All rights reserved.